** Research | Phenotyping LC Patients
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
arious components such as Antithrombin III, Complement C5, and Factor B were measured at different intensities and fold changes, with a follow-up at 6 months. The study aimed to identify biomarkers associated with Long Covid and recovery.
Exploring the complexities of Post-Infectious Fatigue Syndromes reveals a landscape where diagnostic criteria overlap, prevalence data is scarce, and core symptoms persist, hinting at a shared pathophysiology underlying chronic disability post-infection.
Cognitive slowing emerges as a distinct marker in post-COVID-19 conditions, setting apart survivors with enduring symptoms. The pronounced delays observed in simple reaction time tasks signal a potential key factor contributing to cognitive impairments, marking a critical aspect of the post-COVID-19 cognitive landscape.
Centers for Disease Control and Prevention (CDC) reported that approximately 10-30% of COVID-19 patients experience prolonged symptoms.
A study suggests that individuals hospitalized with flu face a heightened risk of long-term health issues, akin to long Covid.
Researchers investigated immune and hormonal differences in individuals with Long COVID compared to those without. They found significant variations, including higher levels of specific immune cells, stronger antibody responses to SARS-CoV-2 and Epstein-Barr virus (EBV), and lower levels of the stress hormone cortisol in Long COVID patients.
In the face of healthcare disparities and persistent symptoms, LGBTQ+ survivors are forging paths to healing through solidarity, advocacy, and resilience
This study on persistent COVID-19 symptoms in survivors from Lagos State, Nigeria, reveals that 40.9% of patients experience ongoing health issues like fatigue and headaches. It underscores the importance of continuous post-discharge monitoring to improve survivors' quality of life.
The COVID-19 pandemic has disproportionately affected Indigenous and racialized women, exacerbating existing inequalities and highlighting systemic issues.